In a bid to push personalized medicine forward, an ambitious ground-breaking £200 million project will see the 500,000 BioBank participants' whole genomes sequenced.READ MORE
Failed drugs often are left on the shelf to gather dust. But sometimes, drugs can be dusted down and repurposed. That’s exactly the route that Katexco Pharmaceuticals has taken with its new immune system-targeting compounds, part of a new life sciences company that aims to target everything from multiple sclerosis to chronic pain.READ MORE
At the British Neuroscience Association (BNA)’s Festival of Neuroscience , we sat down with some influential neuroscientists to discuss their work. Here, we interview University College London Professor Uta Frith on her pioneering work into the neurodevelopmental condition autism spectrum disorder.
Elon Musk has never been afraid to push the envelope when working towards a more innovative future. One of Musk's latest projects, called Neuralink, wants to help people interact with computers by using their minds. Here, we take a look at Musk's claims that Neuralink will bring brain-machine interfaces to the public.
Researchers have conducted a genome-wide association of over 470,000 people to explore whether there are genetic variants that predict whether an individual will engage in same sex behavior.READ MORE
At the British Neuroscience Association's Festival of Neuroscience, we were lucky enough to sit down with some influential neuroscientists to discuss their work. We’ve assembled these transcripts into our BNA Interview Series. Here we interview Professor Michael Meaney, whose work explores the intersection between stress, maternal care and gene expression.READ MORE
At the British Neuroscience Association (BNA)’s Festival of Neuroscience in April 2019, we were lucky enough to sit down with some influential neuroscientists to discuss their work. Here we interview University College London’s John Hardy, whose work into the genetics of neurodegenerative disorders saw him share the Brain Prize in 2018.READ MORE
The brain is an immensely complex structure, but there are ways we can divide up its anatomical structure into more discrete parts. One common divider is to separate the brain’s gray and white matter. But what are these two structures? How different are they from each other? How significant, and physiologically relevant, is this divide?READ MORE
Having strains and cell lines that have been checked and confirmed to be what it says on the tube is invaluable to scientific validity and integrity, saving untold time and money. We spoke to Mindy Goldsborough, Ph.D., Chief Science and Technology Officer, VP and General Manager, ATCC Cell Systems about the importance and challenges of maintaining authenticated cell lines for scientific research.READ MORE